{
    "symbol": "HR",
    "quarter": 2,
    "year": 2022,
    "date": "2022-08-09 22:43:05",
    "content": " Yes, I would say that we're looking at that as sort of the pros merger once we're going to complete the asset sales and JV transactions associated with the special dividend and funding that and then moving into that next phase of really looking at refining -- continuation of refining the portfolio and looking at opportunities where we can exit markets where we don't see a long-term growth strategy through clustering and working with our health system partners and really rotate out of those types of assets and those types of properties and into transaction properties where we do are buying in existing markets and building out clusters."
}